Atlas Trials

Cohort Study of Prospective Validation of Predictive Factors and Biological Imaging of Response to Bevacizumab and Paclitaxel in Patients With Metastatic Breast Cancer

Clinical trial NCT01745757 · COMPLETED

Trial details

NCT number
NCT01745757
Sponsor
UNICANCER
Status
COMPLETED
Study type
OBSERVATIONAL
MetastaticBreast Cancer
Start date
2012-06-01
Primary completion
2022-06-01
Enrollment
510

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.